Cholix toxin (ChxA) is an exotoxin reported in Vibrio cholerae non-O1/non-O139. Apart from its prototype (ChxA I) we have recently identified two novel variants of this toxin, ChxA II and ChxA III. Our previous investigations indicated that the first two variants may instigate extra-intestinal infections and ChxA II can be more lethal than ChxA I in mice. However, all three cholix toxins (ChxA I to III) failed to show any enterotoxicity in rabbit ileal loops. In this study we developed a PCR-restriction fragment length polymorphism (RFLP) assay to differentiate all three chxA variants to further understand the importance of each subtype. By using 53 V. cholerae non-O1/ non-O139 strains harbouring chxA genes, which were previously categorized by sequencing, and various other strains as negative controls, the PCR-RFLP assay showed 100 % typability and specificity. Furthermore, when applied to differentiate additional V. cholerae strains, which were also screened for the chxA gene by colony hybridization, this assay identified chxA I and chxA II genes among 18.5 % and 4.5 % of non-O1/non-O139 strains (n5178), respectively. One non-O1/non-O139 strain was untypable due to the insertion of an IS911-like element. Interestingly, the chxA I gene was detected in 10 out of 137 cholera toxin gene-negative V. cholerae O1 strains. These results suggest that the PCR-RFLP assay developed in this study can be a rapid and simple method to differentiate the chxA subtypes.
INTRODUCTION
Vibrio cholerae, the causative agent of cholera, is a Gramnegative, curved shaped, motile bacterium with a monotrichous flagellum, and is transmitted through contaminated water and food. To date, .200 serogroups of this species have been reported. Among them, only toxigenic V. cholerae O1 and O139, which produce cholera toxin (CT) and toxin co-regulated pilus (TCP), have been responsible for cholera. The other serogroups, termed non-O1/non-O139, have been associated with sporadic cases of diarrhoea or extra-intestinal infection. Although, type III (T3SS) and type VI (T6SS) secretion systems, heat-stable enterotoxin (NAG-ST), haemagglutinin protease (HAP) and zonula occludens toxin (ZOT), etc. have been reported as virulence factors of V. cholerae non-O1/non-O139 (Fasano et al., 1991 (Fasano et al., , 1995 Sarkar et al., 2002; Dziejman et al., 2005; Ghosh et al., 2006; Pukatzki et al., 2006) , pathogenesis of V. cholerae non-O1/non-O139 has not yet been fully understood. ADPribosylation by protein toxins is one of the key mechanisms of modifying the properties of host cell proteins to induce toxicity. Jørgensen et al. (2008) reported the presence of a eukaryotic elongation factor 2 (eEF2)-specific ADP-ribosyltransferase termed cholix toxin (ChxA) in V. cholerae non-O1/non-O139 strains. The ability of the chxA gene to produce an exotoxin was initiated by the discovery of an ORF in an environmental and clinical non-O1/non-O139 V. cholerae strain which showed close sequence similarity with the toxA gene of Pseudomonas aeruginosa encoding the exotoxin A (Purdy et al., 2005; Chen et al., 2007) . The chxA gene encodes a 666 aa protein, which includes a 32 aa leader peptide. Thus, the mature protein is 634 aa with a molecular mass of~71 kDa. ChxA consists of three structural domains for receptor binding, translocation and catalysis (Jørgensen et al., 2008) . Jørgensen et al. (2008) suggested that ChxA may be an important virulence factor of V. cholerae that likely plays a IP: 54.70.40.11
On: Tue, 01 Jan 2019 23:44:38 significant role in the survival of the organism in an aquatic environment. Similarly, Purdy et al. (2010) proposed that ChxA may promote parasitic or mutualistic associations with eukaryotic organisms in the aquatic environment and/ or enhance virulence during inflammatory gastrointestinal disease in humans. Recently, we reported the occurrence and genetic diversity of chxA in V. cholerae, showing its presence extensively in non-O1/non-O139 strains of both clinical and environmental origin but not in the strains belonging to the O1/O139 serogroups (Awasthi et al., 2013) . We observed high genetic diversity of the chxA gene and revealed for the first time the existence of at least two chxA variants (chxA II and III) in addition to the prototype chxA (chxA I), with varied biological activities. While ChxA I and ChxA II showed variable cytotoxic effects on different eukaryotic cells, ChxA III failed to show any such effect. None of the cholix toxins showed enterotoxicity in rabbit ileal loops. In contrast, intravenous injections of ChxA I and ChxA II can kill mice due to extensive damage to internal organs, especially the liver. Since ChxA II killed mice more rapidly, this result suggested that ChxA II is more lethal than ChxA I. This was the first comprehensive study on ChxA to understand its role in V. cholerae pathogenesis (Awasthi et al., 2013) .
Considering the above-mentioned perspectives of ChxA in V. cholerae pathogenesis, it would be important to characterize the chxA gene subtypes. To date there are no reports of molecular methods, except for sequencing analysis, for the detection as well as differentiation of chxA genes. In this study, we have developed a simple and rapid PCRrestriction fragment length polymorphism (RFLP) assay for the detection and differentiation of three chxA subtypes and evaluated the typability and specificity of the assay by using various V. cholerae strains. This method can be used for screening of pathogenic V. cholerae from clinical and environmental samples to further study the diverse role of chxA variants in more detail.
METHODS
Bacterial strains and growth conditions. Apart from chxA genepositive V. cholerae strains (n553) and O139 strains (n589) reported previously (Awasthi et al., 2013) , other V. cholerae O1 and non-O1/ non-O139 strains were randomly selected from our laboratory collections (Table 1) . Moreover, strains belonging to 18 other species of the genus Vibrio and bacterial strains from five other genera (Campylobacter, Escherichia, Shigella, Salmonella and Photobacterium) were also used in this study as shown in The identity of the V. cholerae strains including O1 and O139 serogroups and biotypes was confirmed by standard phenotypic as well as molecular methods (Hoshino et al., 1998; Neogi et al., 2010) . The Vibrio strains stored as glycerol stocks at 280 uC were grown in alkaline peptone water (APW) and subsequently on thiosulfate citrate bile salts sucrose (TCBS) agar or in Luria-Bertani (LB) medium at 37 uC. Escherichia coli and Shigella spp. were cultured in LB medium at 37 uC whereas Salmonella spp. and Photobacterium spp. were grown in trypticase soy medium at 37 uC. All Campylobacter strains were grown under microaerophilic condition according to Asakura et al. (2007) . The Campylobacter strains were cultured on blood base agar supplemented with 5.0 % (v/ v) defibrinated horse blood under microaerophilic conditions (5.0 % O 2 , 10 % CO 2 and 85 % N 2 ) at 37 uC for 48 h.
Chemicals and enzymes. Chemicals were purchased from Nacalai Tesque, Wako Pure Chemical Industries or Sigma. Restriction enzymes and rTaq were purchased from Takara Bio. LB broth base was purchased from Difco. APW was purchased from Nissui Pharmaceutical and TCBS agar was from Eiken Chemical. Blood base agar no. 2 was from Oxoid. Defibrinated horse blood was purchased from Nippon Bio-Support Center (Tokyo, Japan). Trypticase soy broth (TSB) was from Becton Dickinson. Seakem LE agarose was from Lonza. Molecular mass markers were purchased from Bio-Rad or Nippon Genetics.
DNA template preparation. Template DNA of Vibrio spp. as well as other enteric pathogens, including Escherichia spp., Shigella spp., Salmonella spp. and Photobacterium spp. was prepared by the boiling method (Hoshino et al., 1998) . In brief, a single colony was inoculated into 3.0 ml LB or TSB broth and incubated at 37 uC overnight with shaking (180 r.p.m.). The culture was diluted 10 times with TE buffer (10 mM Tris/HCl, 1.0 mM EDTA, pH 8.0) and boiled for 10 min followed by snap cooling on ice. After centrifugation at 8900 g for 3 min, the supernatant was used as DNA template and stored at 230 uC for future use. The DNA templates for Campylobacter spp. were also prepared by the boiling method. A loopful of Campylobacter spp. from blood agar medium was suspended in TE buffer and then processed as described above.
Colony hybridization. The presence of the chxA gene was examined by colony hybridization assay as described previously (Lin et al., 1993) . In brief, V. cholerae strains were grown on nitrocellulose membrane (Schleicher & Schuell) overlaid on LB agar at 37 uC for 4-6 h. Colonies were then lysed and DNA was denatured in situ by the alkaline lysis method followed by UV cross-linking. The chxA gene probe was prepared by PCR as described previously (Awasthi et al., 2013) (Awasthi et al., 2013) , were aligned and the primers were designed from two conserved zones, irrespective of the subtypes. The expected amplicon size was~1.1 kb. In a 20 ml PCR mixture, 1.0 ml boiled DNA template was added to 0.5 U Takara rTaq DNA polymerase, its buffer system (Takara Bio), a forward primer chxAF2 (59-GAAATATCATCGAGGTGCC-39) and a reverse primer chxAR2 (59-AACTTCAGCGTGAGTTGC-39). PCR was carried out in a TaKaRa PCR Thermal Cycler Dice (Takara Bio) with an initial denaturation at 94 uC for 2 min, followed by 30 cycles of denaturation at 94 uC for 30 s, annealing at 56 uC for 30 s, extension at 72 uC for 45 s, and a final extension step at 72 uC for 3 min. The PCR products were subjected to 1.2 % LE agarose gel electrophoresis in TAE buffer (40 mM Tris/acetate, 1.0 mM EDTA, pH 8.0). The gel was stained with ethidium bromide (2 mg ml 21 ) and destained with distilled water. Images were captured using a Gel-Doc 2000 (Bio-Rad). Approximately 5.0 ml of PCR amplicon (~1.1 kb) was subjected to restriction digestion with 10 U EcoRV and BanII in H buffer [50 mM Tris/HCl (pH 7.5), 10 mM MgCl 2 , 1.0 mM dithiothreitol, 100 mM NaCl] at 37 uC for 4-6 h. The digests were subjected to 2.0 % LE agarose gel electrophoresis in TAE buffer and the gel was treated as described above.
Sequencing of the chxA gene. Sequencing analysis for all chxA genes (n553) detected in the V. cholerae non-O1/non-O139 strains from the previous study was performed as previously described (Awasthi et al., 2013) . In the present study, DNA sequencing analysis was performed for all the chxA genes detected in V. cholerae strains during this study to compare the results with the PCR-RFLP assay developed, following standard sequencing analysis methods as described previously (Awasthi et al., 2013) . Briefly, PCR-amplified chxA gene was purified using a QIAquick PCR purification kit (Qiagen) and then subjected to cycle sequencing using a BigDye terminator v 1.1 cycle sequencing kit (Life Technologies). The product was then purified using a Clean Seq kit (Beckman Coulter) and 
RESULTS

Development of PCR-RFLP
The newly designed primers were used to amplify the chxA gene from the DNA templates of V. cholerae strains that were positive for the chxA gene by colony hybridization as well as the chxA gene-negative V. cholerae strains, other vibrios and strains from other genera. The amplified region from the chxA gene variants have distinct restriction sites for EcoRV and BanII restriction enzymes, which are exploited for their typing via RFLP ( Fig. 1 and Table 2 ). (n51), indicating that the specificity of the newly developed PCR-RFLP assay is also 100 % ( Table 1) .
Detection of chxA genes by colony hybridization
To further evaluate the efficiency of the PCR-RFLP assay developed, we attempted to detect the chxA gene in more number of strains other than those reported previously (Awasthi et al., 2013) . Using colony hybridization, the presence of the chxA gene was examined with the V. cholerae O1 (n5137) and non-O1/non-O139 strains (n5178). Because of the limitation in availability of V. cholerae O139 we could not analyse the presence of the chxA gene in a greater number of O139 strains. Interestingly, we could detect the chxA gene in 10 out of 137 V. cholerae O1 strains tested. All of these are ctx gene-negative strains. Furthermore, the chxA gene was also detected in 42 out of 178 V. cholerae non-O1/non-O139 strains by colony hybridization (Table 1) .
PCR-RFLP for chxA toxinotypes
The target region of the chxA was amplified by PCR using newly designed primers and the DNA templates prepared from the chxA gene-positive strains analysed in this study. These primers yielded the specific amplicon from all the chxA gene-positive V. cholerae strains including ctx genenegative V. cholerae O1, except for one V. cholerae non-O1/ non-O139 strain, C85 (Fig. 1, lane 19) . Strain C85 gave an amplicon of greater size than expected, i.e.~1.7 kb instead of~1.1 kb.
The RFLP analysis of the PCR amplicons digested with
EcoRV and BanII typed all 10 chxA genes obtained from V. cholerae O1 as chxA I, whereas 33 and 8 of the V. cholerae non-O1/non-O139 chxA genes were typed as chxA I and chxA II, respectively. The results of the PCR-RFLP assay were confirmed by the sequencing analysis of these chxA genes (Fig. 2) . The chxA gene from strain C85 was untypable ( Fig. 1 and Table 1 ). None of the chxA genes detected in this study belonged to chxA III. The analysis of the complete chxA gene sequence from strain C85 revealed the substitution of 687 bp of the chxA gene with an insertion sequence (IS) element of 1261 bp. The BLAST analysis with this sequence indicated the IS element as a close match to IS911 (transposase OrfAB).
DISCUSSION
The ChxA was reported as a possible virulence factor in V. cholerae non-O1/non-O139 strains (Jørgensen et al., 2008) . In addition to its prototype (ChxA I) we have recently identified two novel variants, ChxA II and ChxA III, of this toxin. Our previous investigations indicated that the first two variants may instigate extra-intestinal infections and ChxA II can be more lethal than ChxA I in mice (Awasthi et al., 2013) . ChxA is also thought to play an important role in environmental fitness (Jørgensen et al., 2008; Purdy et al., 2010) . V. cholerae. The PCR-RFLP assay developed in this study can be very useful in detecting and typing the ChxA toxinotypes.
The results obtained in this study indicate that the newly developed PCR-RFLP assay provides an accurate assay with high typability for characterizing the chxA gene in V. cholerae. The use of the EcoRV and BanII enzymes to digest a target-amplified region of the chxA gene readily produces identifiable differences in restriction digestion patterns sufficient to distinguish the three chxA variants. Among the 53 strains that were previously reported to possess the chxA gene and divided into three types, chxA I (n533), chxA II (n516) and chxA III (n54) were typed with 100 % efficiency (Table 1) using the PCR-RFLP assay developed in this study. The fidelity of the typability observed attests this assay as an excellent typing method.
During our previous study, we exclusively detected the chxA gene in V. cholerae non-O1/non-O139 (27.0 %; 53 out of 196) but not in strains belonging to O1 (n5485) or O139 (n584) serogroups (Awasthi et al., 2013) . However, analysis of a greater number of strains in this study has revealed the occurrence of the chxA gene in V. cholerae O1 strains, although at a low frequency (10 out of 137) (Table  1) . Purdy et al. (2010) previously reported the existence of the chxA gene in V. cholerae O1 originating from Mexico. The O1 strains analysed in this study were isolated in India, indicating for the first time the occurrence of the chxA gene in a few V. cholerae O1 strains originating from the Indian subcontinent. Interestingly, analysis of these chxA genes in O1 strains by our PCR-RFLP assay has identified all of them as belonging to the chxA I subtype. PFGE fingerprinting analysis of these chxA-positive O1 strains (n510) indicates that they belong to the closely related pulsotypes and are possibly clonal (Fig. S1 , available in the online Supplementary Material).
The PCR-RFLP of the 42 chxA genes newly detected in V. cholerae non-O1/non-O139 during this study revealed that 33 and 8 belonged to chxA I and chxA II, respectively. The predominant occurrence of chxA I (33 out of 42,~79 %) as revealed by PCR-RFLP assay is in congruence with our earlier observation by sequencing analysis of chxA genes (33 out of 53,~63 %) (Awasthi et al., 2013) . In this study we could not detect the chxA III gene in any V. cholerae strains tested. Due to the limitation of V. cholerae O139 strains we were unable to assess the presence of the chxA gene in this serogroup; however, we could not rule out the possibility of the chxA gene in this serogroup.
One chxA gene from the V. cholerae non-O1/non-O139 strain C85 was untypable (Table 1) . Strain C85 yielded an amplicon which was~0.6 kb larger than the expected size (Fig. 1, lane 19) . The chxA gene from this strain had a substitution of a~0.7 kb region with a 1261 bp IS element. This IS element has 77 % similarity to IS911 (encoding transposase OrfAB) belonging to the IS3 group. The insertion of an IS element in the chxA gene of strain C85 unveils an interesting recombination event. The significance of the insertion of an IS element (1261 bp), along with the substitution of a~0.7 kb region, in the chxA gene of this strain cannot be ascertained from the limited information on the chxA gene available. The occurrence of IS911 in other enteric pathogens, e.g. E. coli, Shigella flexneri, etc. is frequently linked to disruption of genes mostly involved in signal transduction, intracellular trafficking and cell motility, which probably may aid in natural selection against some of these genes (Licznar et al., 2003; Zaghloul et al., 2007) . As expected, the bead-ELISA developed for ChxA also failed to detect expression of the toxin in strain C85 (data not shown).
In conclusion, we have developed a PCR-RFLP assay that can differentiate the three chxA variant genes (chxA I, II and III) into their respective subtypes with high efficiency.
An interesting observation in this study is the detection of the presence of the chxA gene in V. cholerae O1 strains. This PCR-RFLP will be useful in countries or laboratories where V. cholerae infections are prevalent and availability of sequencing tools is limited. This simple and rapid assay can be considered as highly beneficial because of its applicability. Altogether, our data clearly demonstrate that the PCR-RFLP assay is a simple and reliable method for the differentiation of the three chxA variant genes of V. cholerae.
